Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Find therapies in clinical trials near you – page 175

recruiting
3 968
countries
28
conditions
2 103

3 968 trials match your criteria

Intracranial aneurysm

Recruiting

Study on Managing Risk Factors in Patients with Unruptured Brain Aneurysms Using Carbasalate Calcium and Intensive Blood Pressure Treatment

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid

Nervous system disorder

Recruiting

Study on the Physical Impact of Multiple Sclerosis and Continued Access to Ocrelizumab for Patients Previously in a Related Study

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Ocrelizumab

Short-bowel syndrome

Recruiting

Study on the Effects of Rivaroxaban in Patients with Short Bowel Syndrome on Long-Term Parenteral Nutrition

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Rivaroxaban

Type 1 diabetes mellitus+1

Recruiting

Study on Lisdexamfetamine and Methylphenidate for Children with ADHD and Type 1 Diabetes

Registered drugNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Lisdexamfetamine Dimesylate

Systemic lupus erythematosus

Recruiting

Study on the Effects of Rituximab and Obinutuzumab in Patients with Systemic Lupus Erythematosus (SLE)

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab

Squamous cell carcinoma of head and neck+7

Recruiting

Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab

Pelvic exenteration

Recruiting

Study on Indocyanine Green for Evaluating Blood Flow in Surgery for Women with Recurrent or Persistent Gynecological Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Indocyanine Green

Inflammatory bowel disease+1

Recruiting

Study on the Safety of Faster Infusions for Cancer Patients Using Trastuzumab, Bevacizumab, and Atezolizumab

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab

Squamous cell carcinoma of skin

Recruiting

Study on Cemiplimab for Patients with High-Risk Stage III/IV Cutaneous Squamous Cell Carcinoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab

Assisted fertilisation

Recruiting

Study on the Effect of Lutropin Alfa to Improve Ovarian Reserve in Patients Undergoing IVF/ICSI Due to Tubal, Male Factor, or Unexplained Infertility

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Lutropin Alfa

Soft tissue sarcoma

Recruiting

Study on Trabectedin and Radiotherapy for Patients with Soft Tissue Sarcoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Trabectedin

Systemic lupus erythematosus

Recruiting

Study on the Effects of Belimumab for Patients with Systemic Lupus Erythematosus (SLE)

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Belimumab

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.